SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-020648
Filing Date
2017-03-14
Accepted
2017-03-14 19:33:46
Documents
1
Period of Report
2017-03-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4013
  Complete submission text file 0001209191-17-020648.txt   5458
Mailing Address 350 CAMBRIDGE AVE SUITE 350 PALO ALTO CA 94306
Business Address 350 CAMBRIDGE AVE SUITE 350 PALO ALTO CA 94306 650-279-9845
Eiger BioPharmaceuticals, Inc. (Issuer) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address 350 CAMBRIDGE AVE, SUITE 350 PALO ALTO CA 94306
Business Address
Martins Eduardo Bruno (Reporting) CIK: 0001670431 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36183 | Film No.: 17689469